Neoplants
- Company typePrivate
- Founded2018
- HeadquartersParis, France
- Headcount11–50
- GTM typeB2C
- OfferingHardware or Manufacturing
What Neoplants does
Neoplants is a Paris-based biotechnology company founded in 2018 that engineers houseplants to absorb and break down indoor air pollutants, specifically formaldehyde and BTEX compounds (benzene, toluene, ethylbenzene, and xylene). Its core technology relies on proprietary genetic modifications developed over four years of research and is embodied in its first consumer product, the Neo P1, a living houseplant marketed as a natural alternative to mechanical air purifiers. The company is incorporated in Delaware as Neoplants Inc. and operates with a team of 11-50 employees led by co-founders Lionel Mora (CEO) and Patrick Torbey (CTO).
Neoplants sells directly to consumers through a Shopify-hosted e-commerce storefront, opening pre-orders for the Neo P1 in early 2023. The website exposes a global country selector covering most international markets, indicating a D2C distribution model rather than retail partnerships. The primary customer segment is health-conscious individual consumers seeking natural indoor air purification solutions, differentiated from filter-based purifiers by being a living, maintenance-light product with aesthetic value.
The company's revenue model centers on hardware sales of genetically modified plants, with pricing not publicly disclosed. In October 2022, Neoplants raised $20 million led by Heartcore Capital (with Collaborative Fund, Entrepreneurs First, Exfi, Partech, and True Ventures) to expand the technology platform into additional plant species and carbon capture applications. The company's current commercial website messaging ("A new chapter is taking root. Stay tuned") suggests the consumer product line may be in transition, with future revenue potentially diversifying into B2B climate applications.
Neoplants firmographics
Firmographics- Name
- Neoplants
- Legal name
- Neoplants Inc.
- Website
- https://neoplants.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Neoplants industry classification
Industry- Product category
- Biotech Indoor Air Purification Plants
- akta.pro primary industry
- Eco-Friendly Air Care & Odor Control (CRAJAOAI)
Keywords
Where Neoplants is headquartered
LocationHeadquarters
- HQ city
- Paris
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
Neoplants business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations
Revenue model
- Genetically Modified Plant Sales: Primary revenue stream from selling genetically modified houseplants (Neo P1) directly to consumers. The product was offered via pre-order in early 2023 after four years of research and development. Future revenue may expand to additional plant varieties and carbon capture applications.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Neoplants product offering
Product offeringCore offering
Neoplants engineers genetically modified houseplants that absorb and break down indoor air pollutants, including formaldehyde and BTEX compounds (benzene, toluene, ethylbenzene, and xylene). The company sells these living air-purifying plants directly to consumers via its Shopify-powered e-commerce storefront, with the Neo P1 as its flagship product developed over four years of dedicated biotechnology research and development.
Product overview
Neoplants is a biotechnology company specializing in plant engineering for environmental applications. Their product portfolio centers on the Neo P1, a genetically modified houseplant designed to absorb air pollutants including formaldehyde and BTEX compounds. The company is working to expand this technology to other plant varieties and applications such as carbon capture.
Differentiator
Problem solved
Functional benefit
Brands
- Neo P1: Genetically modified houseplant designed to absorb air pollutants such as formaldehyde and BTEX compounds. The company's first consumer product.
Products and services
- Neo P1 The Neo P1 is a genetically modified houseplant engineered to absorb and remove formaldehyde and BTEX compounds (benzene, toluene, ethylbenzene, and xylene) from indoor air. It was developed after four years of dedicated biotechnology R&D and represents Neoplants' first commercial product, designed for individual consumers seeking natural, low-maintenance indoor air quality solutions.
Quantifiable outcome
- Absorbs formaldehyde and BTEX compounds from indoor air
Companies that use Neoplants
Customer profileSegments1 record
Ideal customer profiles1 record
Neoplants technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature3 records
Neoplants partnerships and signals
Strategic signalScale indicators2 records
Recent moves6 records
Expansion highlights4 records
Neoplants competitors and assessment
Company assessmentOthers
- Pivot Bio: Pivot Bio applies synthetic biology to crop microbes for nitrogen fixation — comparable biotech DNA and engineering-of-living-organisms thesis to Neoplants, but deployed in agriculture rather than consumer household products.
- Ginkgo Bioworks: Ginkgo Bioworks is a large synthetic biology platform engineering organisms for industrial applications — same underlying biotech foundation as Neoplants but serving industrial customers, providing a useful comparable for platform valuation.
Emerging players
- Awair: Awair is a smaller US indoor air quality monitoring and remediation startup focused on chemical sensitivity consumers, comparable target persona to Neoplants but with a sensing/filter combination rather than bioengineered plants.
- Airthings: Airthings makes consumer indoor air quality monitors (radon, VOCs, CO2) and is extending into remediation — same end use case of indoor air awareness but with sensing rather than active purification.
- Rabbit Air: Rabbit Air is a smaller US premium air purifier brand focused on design-conscious consumers and specialty filters — overlapping consumer persona with Neoplants but with a mechanical HEPA-based product.
Broad incumbents
- IQAir: IQAir is a premium air purifier brand specializing in HEPA and HyperHEPA filtration for residential and medical-grade indoor environments, addressing the same formaldehyde/VOC concerns as Neoplants with established clinical positioning.
- Dyson: Dyson is a global broad-line appliance and air purifier incumbent with Purifier Cool/Heater lines, competing for the same indoor air quality wallet but with a much wider product portfolio and far larger R&D and marketing budget.
- Blueair: Blueair is a long-established premium air purifier brand acquired by Unilever, selling HEPASilent technology worldwide — comparable end use case as Neoplants but with broader distribution and retail presence.
- Coway: Coway is a leading Korean home appliance brand with a sizable air purifier line (Icon, Airmega), competing in the same indoor air quality category with strong APAC distribution and lease/subscription models.
Direct peers
- Molekule: Molekule is a direct-to-consumer air purifier company using a proprietary PECO technology to destroy indoor pollutants. It targets the same health-conscious consumer use case as Neoplants with a science-driven, premium-positioned narrative.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Neoplants social profiles
Digital presenceNeoplants financial estimates
Financial estimateRevenue estimate
Valuation estimate
Neoplants leadership team
Management profileNumber of profiles
Profiles2 records
Neoplants funding detail
Funding detailFunding overview
Funding rounds2 records
Investors8 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Neoplants M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Neoplants
What does Neoplants do?
Neoplants engineers genetically modified houseplants that absorb and break down indoor air pollutants, including formaldehyde and BTEX compounds (benzene, toluene, ethylbenzene, and xylene). The company sells these living air-purifying plants directly to consumers via its Shopify-powered e-commerce storefront, with the Neo P1 as its flagship product developed over four years of dedicated biotechnology research and development.
Is Neoplants a public or private company?
Neoplants is a private company. It is classified as venture growth investor backed and is currently operating.
When was Neoplants founded?
Neoplants was founded in 2018. It employs 11 to 50 people.
Where is Neoplants based?
Neoplants is headquartered in Paris, France, in the Europe region.
How does Neoplants make money?
One revenue line is on record: genetically Modified Plant Sales.
Who are Neoplants's main competitors?
Others on record are Pivot Bio and Ginkgo Bioworks. Emerging players are Awair, Airthings and Rabbit Air. Broad incumbents are IQAir, Dyson, Blueair and Coway. Molekule is listed as a direct peer.
Does Neoplants have an API?
No public API is recorded for Neoplants.
What industry is Neoplants in?
Neoplants's product category is Biotech Indoor Air Purification Plants. Its primary akta.pro industry code is CRAJAOAI, Eco-Friendly Air Care & Odor Control.